BDBM337383 US9745317, 21::US9745317, 22::US9745317, 23

SMILES Cc1cc(Oc2nccc3OCCc23)ccc1-c1c(C)ncc(=O)n1C

InChI Key InChIKey=UFCHEYKISFOGMJ-UHFFFAOYSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 337383   

TargetD(1A) dopamine receptor(Human)
Pfizer

US Patent
LigandPNGBDBM337383(US9745317, 22 | US9745317, 23 | US9745317, 21)
Affinity DataKi:  82.5nMAssay Description:D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
US Patent

TargetD(1A) dopamine receptor(Human)
Pfizer

US Patent
LigandPNGBDBM337383(US9745317, 22 | US9745317, 23 | US9745317, 21)
Affinity DataKi:  202nMAssay Description:D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
US Patent

TargetD(1A) dopamine receptor(Human)
Pfizer

US Patent
LigandPNGBDBM337383(US9745317, 22 | US9745317, 23 | US9745317, 21)
Affinity DataKi:  706nMAssay Description:D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
US Patent